CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis
CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis
复制标题
DOI:
10.1038/nm.2691
复制
发表时间:
2012-04-01
期刊:
影响因子:
82.9
通讯作者:
Kasuga, Masato
中科院分区:
文献类型:
--
作者:
Sakai, Mashito;Matsumoto, Michihiro;Kasuga, Masato
During fasting, induction of hepatic gluconeogenesis is crucial to ensure proper energy homeostasis(1). Such induction is dysregulated in type 2 diabetes, resulting in the development of fasting hyperglycemia(2). Hormonal and nutrient regulation of metabolic adaptation during fasting is mediated predominantly by the transcriptional coactivator peroxisome proliferative activated receptor gamma coactivator 1 alpha (PGC-1 alpha) in concert with various other transcriptional regulators(3-8). Although CITED2 (CBP- and p300-interacting transactivator with glutamic acid-and aspartic acid-rich COOH-terminal domain 2) interacts with many of these molecules(9-11), the role of this protein in the regulation of hepatic gluconeogenesis was previously unknown. Here we show that CITED2 is required for the regulation of hepatic gluconeogenesis through PGC-1 alpha. The abundance of CITED2 was increased in the livers of mice by fasting and in cultured hepatocytes by glucagon-cAMP-protein kinase A (PKA) signaling, and the amount of CITED2 in liver was higher in mice with type 2 diabetes than in non-diabetic mice. CITED2 inhibited the acetylation of PGC-1 alpha by blocking its interaction with the acetyltransferase general control of amino acid synthesis 5-like 2 (GCN5). The consequent downregulation of PGC-1 alpha acetylation resulted in an increase in its transcriptional coactivation activity and an increased expression of gluconeogenic genes. The interaction of CITED2 with GCN5 was disrupted by insulin in a manner that was dependent on phosphoinositide 3-kinase (PI3K)-thymoma viral proto-oncogene (Akt) signaling. Our results show that CITED2 functions as a transducer of glucagon and insulin signaling in the regulation of PGC-1 alpha activity that is associated with the transcriptional control of gluconeogenesis and that this function is mediated through the modulation of GCN5-dependent PGC-1 alpha acetylation. We also found that loss of hepatic CITED2 function suppresses gluconeogenesis in diabetic mice, suggesting it as a therapeutic target for hyperglycemia.